Beximco Pharmaceuticals (LON:BXP) Stock Passes Below 200-Day Moving Average of $39.39

Shares of Beximco Pharmaceuticals Limited (LON:BXPGet Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 39.39 ($0.49) and traded as low as GBX 36 ($0.45). Beximco Pharmaceuticals shares last traded at GBX 37 ($0.46), with a volume of 24,443 shares.

Beximco Pharmaceuticals Stock Up 1.4 %

The company has a current ratio of 1.63, a quick ratio of 0.37 and a debt-to-equity ratio of 15.50. The company’s 50 day moving average is GBX 38.77 and its 200 day moving average is GBX 39.39. The company has a market cap of £165.06 million, a PE ratio of 462.50 and a beta of 0.64.

About Beximco Pharmaceuticals

(Get Free Report)

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.

See Also

Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.